At a glance
ClinicalIndex Comparison RecordN/ACompleted· 101 enrolled
Drug / intervention
Testosterone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Collaborative Study: Testosterone Antidepressant Augmentation in Women
In Brief
A clinical study evaluating Testosterone and Placebo for Depression. Completed, enrolled 101 participants across 2 sites.
Detailed Summary
The investigators' hypotheses are: Low-dose testosterone augmentation improves depressive symptoms in women with Major Depressive Disorder (MDD) and antidepressant partial/nonresponse, adjunctive low-dose testosterone is safe and well-tolerated in women with MDD and antidepressant partial/nonresponse, and low-dose testosterone augmentation improves fatigue and sexual dysfunction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), Lawley Pharmaceuticals
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 2013
Enrollment StartAug 2013
Primary CompletionJan 2017
TodayJul 2026
First PostedFeb 5, 2013
Enrollment StartAug 1, 2013
Primary CompletionJan 27, 2017
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 13.4 years ago
Interventions
Testosteronedrug
Placebodrug